UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Eggshell-Derived Fe-Mg Particles and Hydroxyapatite for Removal of Tetracycline and Metronidazole from Aqueous Systems

Journal of hazardous, toxic and radioactive waste, 2024-10, Vol.28 (4)

2024

Volltextzugriff (PDF)

Current approach to Waldenström Macroglobulinemia

Cancer treatment and research communications, 2022, Vol.31, p.100527-100527, Article 100527

2022

Volltextzugriff (PDF)

Sandwich assembly of sulfonated poly (ether sulfone) with sulfonated multiwalled carbon nanotubes as an efficient architecture for enhanced electrolyte performance in H2/O2 fuel cells

International journal of energy research, 2022-03, Vol.46 (3), p.2567-2584

2022

Volltextzugriff (PDF)

Sandwich assembly of sulfonated poly (ether sulfone) with sulfonated multiwalled carbon nanotubes as an efficient architecture for enhanced electrolyte performance in H 2 / O 2 fuel cells

International journal of energy research, 2022-03, Vol.46 (3), p.2567-2584

2022

Volltextzugriff (PDF)

Current diagnosis, risk stratification and treatment paradigms in newly diagnosed multiple myeloma

Cancer treatment and research communications, 2021, Vol.29, p.100444-100444, Article 100444

2021

Volltextzugriff (PDF)

History of drug use in allogeneic hematopoietic cell transplant recipients

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.581-585

2021

Volltextzugriff (PDF)

Bispecific T‐cell engagers for treatment of multiple myeloma

American journal of hematology, 2023-03, Vol.98 (S2), p.S13-S21

2023

Volltextzugriff (PDF)

Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation

Clinical transplantation, 2014-01, Vol.28 (1), p.1-5

2014

Volltextzugriff (PDF)

Outcomes of Patients with Newly Diagnosed Multiple Myeloma Experiencing Treatment Failure after Upfront Quadruplet Therapy and Autologous Stem Cell Transplantationgayathri Ravi 1, Susan Bal 1, Kelly Godby 1, Smith Giri 1, Clare Ubersax 1, Abigail Tucker 1, Luciano J Costa 1

Blood, 2023-11, Vol.142 (Supplement 1), p.1989-1989

2023

Volltextzugriff (PDF)

Synthesis and Application of Chitosan–Graphene Oxide and Titanium-Dioxide Coated Granular Activated Carbon Composites for Adsorptive and Photocatalytic Removal of Antibiotics

Journal of hazardous, toxic and radioactive waste, 2021-10, Vol.25 (4)

2021

Volltextzugriff (PDF)

Drug Class Refractoriness, Not Number of Prior Lines of Therapy (LOT), Properly Classify Patients with Relapsed and Refractory Multiple Myeloma (RRMM) Receiving Contemporary Regimens

Blood, 2022-11, Vol.140 (Supplement 1), p.10084-10085

2022

Volltextzugriff (PDF)

Beyond BCMA: Outcomes of relapsed/refractory multiple myeloma after progression on anti-BCMA T cell redirecting therapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e20026-e20026

2022

Volltextzugriff (PDF)

Bendamustine Lymphodepletion (LD) Prior to Idecabtagene Vicleucel (Ide-cel) Is Associated with Inferior Outcomes in Relapsed Refractory Multiple Myeloma (RRMM)

Blood, 2023-11, Vol.142 (Supplement 1), p.6920-6920

2023

Volltextzugriff (PDF)

Hospital Associated Disability Among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell Transplant

Blood, 2023-11, Vol.142 (Supplement 1), p.3784-3784

2023

Volltextzugriff (PDF)

Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma

British journal of haematology, 2023-03, Vol.200 (6), p.824-827

2023

Volltextzugriff (PDF)

Reinforced Hydroxylated Boron Nitride on Porous Sulfonated Poly(ether sulfone) with Excellent Electrolyte Properties for H 2 /O 2 Fuel Cells

Energy & fuels, 2022-06, Vol.36 (12), p.6445-6458

2022

Volltextzugriff (PDF)

Reinforced Hydroxylated Boron Nitride on Porous Sulfonated Poly(ether sulfone) with Excellent Electrolyte Properties for H2/O2 Fuel Cells

Energy & fuels, 2022-06, Vol.36 (12), p.6445-6458

2022

Volltextzugriff (PDF)

High Dose Fractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone (mHyperCVAD) Is an Active Regimen in Heavily Pretreated Relapsed/Refractory Multiple Myeloma, Enabling Access to Experimental Therapies

Blood, 2021-11, Vol.138 (Supplement 1), p.3784-3784

2021

Volltextzugriff (PDF)

Dual Targeting of Slamf-7 and CD38 in Mulitple Myeloma (MM): A Phase II Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone (Isa-EloPD) in Relapsed and/or Refractory MM (RRMM)

Blood, 2023-11, Vol.142 (Supplement 1), p.3379-3379

2023

Volltextzugriff (PDF)

Safety, Feasibility, and Efficacy of Upfront Daratumumab-Based Therapy in Blacks with Dysproteinemia

Blood, 2022-11, Vol.140 (Supplement 1), p.13198-13199

2022

Volltextzugriff (PDF)

OA-46 Phase II Clinical Trial of Minimal Residual Disease Response-Adapted Deferral of Transplantation in Dysproteinemia (MILESTONE)

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S29-S29

2024

Volltextzugriff (PDF)

P-026 Combined GPRC5D and BCMA-targeted T-cell Redirecting Therapy in the Treatment of RRMM

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S55-S56

2024

Volltextzugriff (PDF)

P-036 BCMA after GPRC5D: Efficacy of BCMA-Directed Therapy on Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Progressing After GPRC5D-Directed Therapy

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S61-S62

2024

Volltextzugriff (PDF)

Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations

British journal of haematology, 2024-04, Vol.204 (4), p.1300-1306

2024

Volltextzugriff (PDF)

Health Outcome Preferences Among Older Adults with Multiple Myeloma Undergoing Systemic Therapy

Blood, 2023-11, Vol.142 (Supplement 1), p.2400-2400

2023

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Englisch
(156)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(39)
Humans
(18)
Technology
(16)
Physical Sciences
(13)
Multiple Myeloma
(10)
Chemistry
(9)
Hematology
(9)
Male
(8)
Engineering
(7)
Female
(7)
Fluorescence
(7)
Oncology
(7)
Cancer
(6)
Chemistry, Multidisciplinary
(6)
Chemical Compounds
(5)
Energy & Fuels
(5)
Materials Science
(5)
Materials Science, Multidisciplinary
(5)
Science & Technology - Other Topics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Eggshell-Derived Fe-Mg Particles and Hydroxyapatite for Removal of Tetracycline and Metronidazole from Aqueous Systems

Current approach to Waldenström Macroglobulinemia

Sandwich assembly of sulfonated poly (ether sulfone) with sulfonated multiwalled carbon nanotubes as an efficient architecture for enhanced electrolyte performance in H2/O2 fuel cells

Sandwich assembly of sulfonated poly (ether sulfone) with sulfonated multiwalled carbon nanotubes as an efficient architecture for enhanced electrolyte performance in H 2 / O 2 fuel cells

Current diagnosis, risk stratification and treatment paradigms in newly diagnosed multiple myeloma

History of drug use in allogeneic hematopoietic cell transplant recipients

Bispecific T‐cell engagers for treatment of multiple myeloma

Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation

Outcomes of Patients with Newly Diagnosed Multiple Myeloma Experiencing Treatment Failure after Upfront Quadruplet Therapy and Autologous Stem Cell Transplantationgayathri Ravi 1, Susan Bal 1, Kelly Godby 1, Smith Giri 1, Clare Ubersax 1, Abigail Tucker 1, Luciano J Costa 1

Synthesis and Application of Chitosan–Graphene Oxide and Titanium-Dioxide Coated Granular Activated Carbon Composites for Adsorptive and Photocatalytic Removal of Antibiotics

Drug Class Refractoriness, Not Number of Prior Lines of Therapy (LOT), Properly Classify Patients with Relapsed and Refractory Multiple Myeloma (RRMM) Receiving Contemporary Regimens

Beyond BCMA: Outcomes of relapsed/refractory multiple myeloma after progression on anti-BCMA T cell redirecting therapy

Bendamustine Lymphodepletion (LD) Prior to Idecabtagene Vicleucel (Ide-cel) Is Associated with Inferior Outcomes in Relapsed Refractory Multiple Myeloma (RRMM)

Hospital Associated Disability Among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell Transplant

Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma

Reinforced Hydroxylated Boron Nitride on Porous Sulfonated Poly(ether sulfone) with Excellent Electrolyte Properties for H 2 /O 2 Fuel Cells

Reinforced Hydroxylated Boron Nitride on Porous Sulfonated Poly(ether sulfone) with Excellent Electrolyte Properties for H2/O2 Fuel Cells

High Dose Fractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone (mHyperCVAD) Is an Active Regimen in Heavily Pretreated Relapsed/Refractory Multiple Myeloma, Enabling Access to Experimental Therapies

Dual Targeting of Slamf-7 and CD38 in Mulitple Myeloma (MM): A Phase II Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone (Isa-EloPD) in Relapsed and/or Refractory MM (RRMM)

Safety, Feasibility, and Efficacy of Upfront Daratumumab-Based Therapy in Blacks with Dysproteinemia

OA-46 Phase II Clinical Trial of Minimal Residual Disease Response-Adapted Deferral of Transplantation in Dysproteinemia (MILESTONE)

P-026 Combined GPRC5D and BCMA-targeted T-cell Redirecting Therapy in the Treatment of RRMM

P-036 BCMA after GPRC5D: Efficacy of BCMA-Directed Therapy on Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Progressing After GPRC5D-Directed Therapy

Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations

Health Outcome Preferences Among Older Adults with Multiple Myeloma Undergoing Systemic Therapy

Suchergebnisse filtern